Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL [Phase 2]

View source ↗

Summary

A Phase 2 multicenter, prospective, open-label randomized study evaluating haploidentical hematopoietic stem cell transplantation with TBI or TMLI conditioning …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Acute Lymphoblastic Leukemia, Adult | Phase 2 | Status: RECRUITING